We supposed that the dramatically suppressed of PBX1 in CRC causing that the source of PBX1 mRNA in silico was mainly from tumor stromal cells and infiltrative immune cells so that the PBX1 level in TCGA could not reflect the actual PBX1 expression in tumor cells. This evidence concerns the gene PBX1 and colorectal carcinoma.